98 related articles for article (PubMed ID: 12171773)
1. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.
Melo MB; Ahmad NN; Lima CS; Pagnano KB; Bordin S; Lorand-Metze I; SaAd ST; Costa FF
Hematology; 2002 Feb; 7(1):13-9. PubMed ID: 12171773
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
3. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
Pavlova S; Mayer J; Koukalova H; Smardova J
Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
[TBL] [Abstract][Full Text] [Related]
4. Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing.
Wang R; Yu Z; Gu J; Li D; Wang M; Cao Y
Chin Med J (Engl); 1998 Apr; 111(4):339-42. PubMed ID: 10374399
[TBL] [Abstract][Full Text] [Related]
5. Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma.
Markaki EA; Tsopanomichalou M; Dimitriou H; Stiakaki E; Perdikoyanni C; Spandidos D; Kalmanti M
Pediatr Hematol Oncol; 2001 Mar; 18(2):101-10. PubMed ID: 11255727
[TBL] [Abstract][Full Text] [Related]
6. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.
Zhang W; Hu G; Estey E; Hester J; Deisseroth A
Oncogene; 1992 Aug; 7(8):1645-7. PubMed ID: 1630824
[TBL] [Abstract][Full Text] [Related]
7. Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia.
Fenaux P; Collyn d'Hooghe M; Jonveaux P; Lai JL; Bauters F; Loucheux MH; Kerckaert JP
Nouv Rev Fr Hematol (1978); 1990; 32(5):341-4. PubMed ID: 2099408
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent events.
Herzog G; Lu-Hesselmann J; Zimmermann Y; Haferlach T; Hiddemann W; Dreyling M
Haematologica; 2005 May; 90(5):693-5. PubMed ID: 15921389
[TBL] [Abstract][Full Text] [Related]
12. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
[TBL] [Abstract][Full Text] [Related]
13. Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias.
Pignon JM; Vinatier I; Fanen P; Jonveaux P; Tournilhac O; Imbert M; Rochant H; Goossens M
Hum Mutat; 1994; 3(2):126-32. PubMed ID: 8199593
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
Sahu GR; Das BR
Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA
Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822
[TBL] [Abstract][Full Text] [Related]
16. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
[TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
19. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P
Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036
[TBL] [Abstract][Full Text] [Related]
20. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
